Myelofibrosis with myeloid metaplasia in young individuals: Disease characteristics, prognostic factors and identification of risk groups

British Journal of Haematology

Volumn 102, Issue 3, 1998, Pages 684-690

  Cervantes, Francisco ^a,e   Barosi, Giovanni ^b   Demory, Jean Loup ^c   Reilly, John ^d   Guarnone, Roberta ^b   Dupriez, Brigitte ^c   Pereira, Arturo ^a   Montserrat, Emilio ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^e HOSPITAL CLÍNIC   (Spain)

Author keywords

Myelofibrosis with myeloid metaplasia; Prognosis; Young patients

Indexed keywords

ALPHA INTERFERON; ANDROGEN; BUSULFAN; CALCITRIOL; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; CYTARABINE; ERYTHROPOIETIN; HYDROXYUREA; MELPHALAN; MERCAPTOPURINE; PIPOBROMAN; PREDNISONE; ZORUBICIN;

ADULT; ARTICLE; CANCER SURVIVAL; DISEASE COURSE; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MYELOFIBROSIS; MYELOID METAPLASIA; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; STEM CELL TRANSPLANTATION; TREATMENT INDICATION; TREATMENT OUTCOME;

CAUSE OF DEATH; FEMALE; HUMANS; MALE; MIDDLE AGED; MYELOFIBROSIS; MYELOID METAPLASIA; PROGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 0031841069     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00833.x     Document Type: Article

References (26)

1. Anderson, J.E., Sale, G., Appelbaum, F.R., Chauncey, T.R. & Storb, R. (1997) Allogeneic marrow transplantation for primary myelofibrosis and myelofibrosis secondary to polycythaemia vera or essential thrombocytosis. British Journal of Haematology, 98, 1010-1016.
2. Barosi, G., Berzuini, C., Liberato, L.N., Costa, A., Polino, G. & Ascari, E. (1988) A prognostic classification of myelofibrosis with myeloid metaplasia. British Journal of Haematology, 70, 397-401.
3. Bouroncle, B. & Doan, C.A. (1962) Myelofibrosis: clinical, haematologic and pathologic study of 110 patients. American Journal of Medical Sciences, 243, 697-715.
4. Burkhardt, R., Bartl, R., Frisch, B., Ketter, G., Mahl, G. & Sund, M. (1986) Working formulation of chronic myeloproliferative disorders based on histological, haematological, and clinical findings. Journal of Clinical Pathology, 59, 237-252.
5. Cervantes, F., Pereira, A., Esteve, J., Rafel, M., Cobo, F., Rozman, C. & Montserrat, E. (1997) Identification of 'short-lived' and 'long-lived' patients at presentation of idiopathic myelofibrosis. British Journal of Haematology, 97, 635-640.
6. Cervantes, F., Robertson, J.E., Rozman, C., Baccarani, M., Tura, S., Gómez, G.A., Braun, T.J., Clarkson, B.D., Pereira, A., and the Italian Cooperative CML Study Group (1994) Long-term survivors in chronic granulocytic leukaemia: a study by the International CGL Prognosis Study Group. British Journal of Haematology, 87, 293-300.
7. Cox, D.R. (1972) Regression models and life tables. Journal of the Royal Statistical Society (B), 34, 187-220.
8. Demory, J.L., Dupriez, B., Fenaux, P., Lai, J.L., Beuscart, R., Jouet, J.P., Deminatti, M. & Bauters, F. (1989) Cytogenetic studies and their prognostic significance in agnogenic myeloid metaplasia: a report on 47 cases. Blood, 72, 855-959.
9. Dupriez, B., Morel, P., Demory, J.L., Lai, J.L., Simon, M., Plantier, I. & Bauters, F. (1996) Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system. Blood, 88, 1013-1018.
10. Guardiola, Ph., Esperou, H., Cazals-Hatem, D., Ifrah, N., Jourt, J.P., Buzyn, A., Sutton, L., Gratecos, N., Tilly, H., Lioure, B. & Gluckman, E. (1997) Allogeneic bone marrow transplantation for agnogenic myeloid metaplasia. British Journal of Haematology 98, 1004-1009.
11. Jacobson, R.J., Salo, A. & Fialkow, P.J. (1978) Agnogenic myeloid metaplasia: a clonal proliferation of hemopoietic stem cells with secondary myelofibrosis. Blood, 5, 189-194.
12. Kaplan, E.L. & Meier, P. (1958) Nonparametric estimations from incomplete observations. Journal of the American Statistical Association, 53, 457-481.
13. Kleinbaum, D.G. (1996) Survival Analysis, pp. 83-128. Springer, New York.
14. Lawler, S.D. & Swansbury, G.J. (1985) Cytogenetic studies in myelofibrosis and related conditions. Myelofibrosis: Pathophysiology and Clinical Management (ed. by S. M. Lewis), pp. 167-194. Marcel Dekker, New York.
15. Lennert, K., Naghai, K. & Schwarze, E.W. (1975) Patho-anatomical features of the bone marrow. Clinics in Haematology, 4, 331-351.
16. Manoharan, A. (1988) Myelofibrosis: prognostic factors and treatment. British Journal of Haematology, 69, 295-298.
17. Mantel, N. (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemotherapy Reports, 50, 163-170.
18. Montserrat, E., Gomis, F., Vallespí, T., Ríos, A., Soler, J., Alcalá, A., Morey, M., Ferrán, C., Díaz-Mediavilla, J., Flores, A., Woessner, S., Batlle, J., González-Aza, C., Rovira, M., Reverter, J.C. & Rozman, C. (1991) Presenting features and prognosis of chronic lymphocytic leukemia in younger adults. Blood, 78, 1545-1551.
19. Morel, P., Demory, J.L. & Dupriez, B. (1997) Relevance of prognostic features in myeloid metaplasia to selection of patients for bone marrow transplantation. (Letter). Blood, 89, 2219-2220.
20. Njoku, O.S., Lewis, S.M., Catovsky, D. & Gordon-Smith, E.C. (1983) Anaemia in myelofibrosis: its value in prognosis. British Journal of Haematology, 54, 79-89.
21. Pereira, A., Cervantes, F., Brugués, R. & Rozman, C. (1990) Bone marrow histopathology in primary myelofibrosis: its value in prognosis. European Journal of Haematology, 44, 94-98.
22. Reilly, J. (1997) Myelofibrosis: pathogenesis, natural history and management. Blood Reviews, 11, 233-242.
23. Reilly, J.T., Snowden, J.A., Spearing, R.L., Fitzgerald, P.M., Jones, N., Watmore, A. & Potter, A. (1997) Cytogenetic abnormalities and their prognostic significance in idiopathic myelofibrosis: a study of 106 cases. British Journal of Haematology, 98, 96-102.
24. Rupoli, S., Da Lio, L., Sisti, S., Campanati, G., Salvi, A., D'Amico, S., Cincipirini, A. & Leoni, P. (1994) Primary myelofibrosis: a detailed statistical analysis of the clinicopathological variables influencing survival. Annals of Hematology, 68, 205-212.
25. Varki, A., Lottenberg, R., Griffith, R. & Reinhard, E. (1983) The syndrome of idiopathic myelofibrosis: a clinico-pathologic review with emphasis on the prognostic variables predicting survival. Medicine (Baltimore), 62, 353-371.
26. Visani, G., Finelli, C., Castelli, U., Petti, M.C., Ricci, C., Vianelli, L., Gianni, L., Zuffa, E., Aloe Spiriti, M.A., Latagliata, R., Pileri, S., Magrini, U., Gugliota, L., Morra, E., Bernasconi, C., Mandelli, F. & Tura, S. (1990) Myelofibrosis with myeloid metaplasia: clinical and haematological parameters predicting survival in a series of 133 patients. British Journal of Haematology, 75, 4-9.